First Citizens BancShares, Inc.
NASDAQ:FCNCABanks - Regional
-$36.07 today
- Market cap
- $24.67B
- Beta
- 0.62
- P/E (TTM)
- 10.9
- EPS (TTM)
- $189.27
- Dividend yield
- 0.40%
Volume 0.05M
Average 0.08M
FCNCA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
First Citizens BancShares, Inc.NASDAQ: FCNCA
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How FCNCA compares with its peers on the latest reported figures
- FCNCA's LTM Sep 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for FCNCA, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding FCNCA) | $0 | -100.0% | — | 0.0% | |
Competitors are the stored peer set for FCNCA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.9B | 5.1B | 12.64B | 14.94B | 14.5B |
| Cost of Revenue | 24M | 1.11B | 5.05B | 5.64B | 5.59B |
| Gross Profit | 1.88B | 3.98B | 7.58B | 9.3B | 8.91B |
| Gross Margin | 98.7% | 78.2% | 60.0% | 62.2% | 61.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 783M | 1.68B | 3.12B | 3.51B | 4.25B |
| Operating Expenses | 1.17B | 2.62B | (4.49B) | 5.71B | 5.94B |
| Depreciation & Amortization | 143M | 533M | (57M) | 130M | 405M |
| EBITDA | 844M | 1.9B | 12.02B | 3.72B | 3.38B |
| EBITDA Margin | 44.4% | 37.2% | 95.1% | 24.9% | 23.3% |
| Operating Income | 701M | 1.36B | 12.08B | 3.59B | 2.97B |
| Operating Margin | 36.9% | 26.7% | 95.6% | 24.0% | 20.5% |
| Interest Income | 1.45B | 3.41B | 10.39B | 12.35B | 11.78B |
| Interest Expense | 61M | 467M | 3.68B | 5.21B | 4.96B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 701M | 1.36B | 12.08B | 3.59B | 2.97B |
| Pre-Tax Margin | 36.9% | 26.7% | 95.6% | 24.0% | 20.5% |
| Income Tax Expense | 154M | 264M | 611M | 815M | 765M |
| Net Income | 547M | 1.1B | 11.47B | 2.78B | 2.21B |
| Net Margin | 28.8% | 21.5% | 90.7% | 18.6% | 15.2% |
| EPS (Basic) | 53.88 | 67.47 | 785.18 | 189.42 | 165.76 |
| EPS (Diluted) | 53.88 | 67.40 | 784.55 | 189.41 | 165.76 |
| Weighted Avg Shares | 9.82M | 15.53M | 14.53M | 14.34M | 12.36M |
| Weighted Avg Shares (Diluted) | 9.82M | 15.55M | 14.54M | 14.34M | 12.36M |
First Citizens BancShares, Inc.
NASDAQ:FCNCA
Intrinsic Alpha fair value
Locked
Current Price
$2,229.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.